Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bill Deakin

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
The Lancet. Psychiatry|May 24, 2020
Assessing adjunctive treatments for bipolar depressionMuhammad Ishrat Husain, Bill Deakin, Imran B Chaudhry, et al.
Scientific Reports|July 7, 2019
The UKB envirome of depression: from interactions to synergistic effectsGabor Hullam, Peter Antal, Peter Petschner, et al.
The Lancet. Psychiatry|September 19, 2020
Trial failures of anti-inflammatory drugs in depression - Authors' replyMuhammed Ishrat Husain, Bill Deakin, Imran B Chaudhry, et al.
Journal of Psychopharmacology (Oxford, England)|October 14, 2011
Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophreniaIvan Koychev, Emma Barkus, Ulrich Ettinger, et al.
Molecular Psychiatry|July 2, 2020
Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesisSilke Conen, Catherine J Gregory, Rainer Hinz, et al.
Journal of Psychopharmacology (Oxford, England)|April 25, 2012
Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatmentImran B Chaudhry, Jaime Hallak, Nusrat Husain, et al.
Journal of Psychiatric Research|August 18, 2009
Neuronal correlates and serotonergic modulation of behavioural inhibition and reward in healthy and antisocial individualsBirgit Völlm, Paul Richardson, Shane McKie, et al.
The International Journal of Neuropsychopharmacology|December 6, 2022
Inflammation and Blood-Brain Barrier in Depression: Interaction of CLDN5 and IL6 Gene Variants in Stress-Induced DepressionZsofia Gal, Dora Torok, Xenia Gonda, et al.
International Journal of Molecular Sciences|October 26, 2024
New Evidence for the Role of the Blood-Brain Barrier and Inflammation in Stress-Associated Depression: A Gene-Environment Analysis Covering 19,296 Genes in 109,360 HumansZsofia Gal, Dora Torok, Xenia Gonda, et al.
Behavioural Brain Research|June 11, 2018
Cerebral oxidative metabolism mapping in four genetic mouse models of anxiety and mood disordersDenis Matrov, Tanel Kaart, Laurence Lanfumey, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
The Lancet. Psychiatry|May 24, 2020
Assessing adjunctive treatments for bipolar depressionMuhammad Ishrat Husain, Bill Deakin, Imran B Chaudhry, et al.
Scientific Reports|July 7, 2019
The UKB envirome of depression: from interactions to synergistic effectsGabor Hullam, Peter Antal, Peter Petschner, et al.
The Lancet. Psychiatry|September 19, 2020
Trial failures of anti-inflammatory drugs in depression - Authors' replyMuhammed Ishrat Husain, Bill Deakin, Imran B Chaudhry, et al.
Journal of Psychopharmacology (Oxford, England)|October 14, 2011
Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophreniaIvan Koychev, Emma Barkus, Ulrich Ettinger, et al.
Molecular Psychiatry|July 2, 2020
Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesisSilke Conen, Catherine J Gregory, Rainer Hinz, et al.
Journal of Psychopharmacology (Oxford, England)|April 25, 2012
Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatmentImran B Chaudhry, Jaime Hallak, Nusrat Husain, et al.
Journal of Psychiatric Research|August 18, 2009
Neuronal correlates and serotonergic modulation of behavioural inhibition and reward in healthy and antisocial individualsBirgit Völlm, Paul Richardson, Shane McKie, et al.
The International Journal of Neuropsychopharmacology|December 6, 2022
Inflammation and Blood-Brain Barrier in Depression: Interaction of CLDN5 and IL6 Gene Variants in Stress-Induced DepressionZsofia Gal, Dora Torok, Xenia Gonda, et al.
International Journal of Molecular Sciences|October 26, 2024
New Evidence for the Role of the Blood-Brain Barrier and Inflammation in Stress-Associated Depression: A Gene-Environment Analysis Covering 19,296 Genes in 109,360 HumansZsofia Gal, Dora Torok, Xenia Gonda, et al.
Behavioural Brain Research|June 11, 2018
Cerebral oxidative metabolism mapping in four genetic mouse models of anxiety and mood disordersDenis Matrov, Tanel Kaart, Laurence Lanfumey, et al.
Pageof 7